P1/2 data • Clinical Trial,Phase I • Clinical Trial,Phase II • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ENG (Endoglin)
|
HR positive • HER-2 negative • HR positive + HER-2 negative
|
everolimus • letrozole • carotuximab IV (ENV-105)